Journal of Applied Physiology Millar Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (October 22, 2009). doi:10.1152/japplphysiol.00704.2009
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cho, J. E.
Right arrow Articles by Lewis, M. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, J. E.
Right arrow Articles by Lewis, M. I.
Submitted on July 2, 2009
Revised on October 7, 2009
Accepted on October 21, 2009

Time Course Expression of Foxo Transcription Factors in Skeletal Muscle Following Corticosteroid Administration

John E. Cho1, Mario Fournier1, Xiaoyu Da1, and Michael I. Lewis2*

1 Cedars-Sinai Medical Center
2 Cedars Sinai Medical Center

* To whom correspondence should be addressed. E-mail: michael.lewis{at}cshs.org.

Increased expression of forkhead box O (Foxo) transcription factors were reported in cultured myotubes and mouse limb muscle with corticosteroid (CS) treatment. We previously reported that administration of CS to rats resulted in muscle fiber atrophy only by day 7. The aim of this study therefore, was to evaluate the time-course changes in the expression of Foxo transcription factors and muscle specific ubiquitin E3 ligases in rat limb muscle following CS administration. Triamcinolone (TR; 1 mg/kg/d, im) was administered for 1, 3, or 7 days. Control (CTL) rats were given saline. Muscle mRNA was analyzed by real-time RT-PCR. Compared to CTL, body weights of TR treated animals decreased by 3, 12 and 21% at days 1, 3 and 7, respectively. Muscle IGF-1 mRNA levels decreased by 33, 65 and 58% at days 1, 3 and 7 in TR treated rats compared to CTL. Levels of phosphorylated Akt were 28, 50 and 36% lower in TR animals at these time points. Foxo1 mRNA increased progressively by 1.2, 1.4 and 2.5-fold at days 1, 3 and 7 in TR animals. Similar changes were noted in the expression of Foxo3a mRNA (1.3, 1.4 and 2.6-fold increments). By contrast, Foxo4 mRNA was not significantly changed in TR animals. With TR, muscle atrophy F box/Atrogin-1 increased by 1.8, 4.1 and 7.5-fold at days 1, 3 and 7 compared to CTL rats. By contrast, muscle RING finger 1 increased only from day 7 (2.7-fold). Gradual reduction in IGF-I expression with TR over the time series, paralleled that of Akt. These findings are consistent with a progressive stimulus to muscle protein degradation and the need to process/remove disassembled muscle proteins via the ubiquitin-proteasome system. Elucidating the dynamic catabolic responses to CS challenge is important in understanding the mechanisms underlying muscle atrophy, and therapeutic measures to offset this.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.